FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2056500690> ?p ?o ?g. }

• W2056500690 endingPage "720" @default.
• W2056500690 startingPage "714" @default.
• W2056500690 abstract "We searched for compounds that are pharmacologically active on ureteral motility for treating ureteral colic to ease retrograde access into the ureter and improve the clearance of stones or stone particles from the ureter. The effects of the alpha1-adrenergic receptor agonist phenylephrine, the nonselective beta and beta2-adrenergic receptor agonists isoproterenol and fenoterol, and the phosphodiesterase inhibitors papaverine (nonspecific) and rolipram (type IV) on the frequency and amplitude of ureteral contractions when administered intravenously or topically were investigated in pigs.A total of 52 pigs were anesthetized. A double lumen 6Fr catheter was inserted through each renal pelvis and into the ureter, allowing perfusion of saline or drug solution into the renal pelvis and the recording of contractions from the mid portion of the ureter.The alpha1 and beta-adrenergic receptors of the ureter are not tonically activated by endogenous epinephrine or norepinephrine. Phenylephrine administered intravenously at a dose of 0.01 to 3 mg./kg. and topically at 0.1 to 3 mg./ml. per minute increased contraction frequency 10 and 4-fold, respectively, and contraction amplitude 2-fold each in a dose dependent manner. Arterial blood pressure increased markedly during intravenous administration of phenylephrine but was minimally affected during topical application. The phenylephrine effects were reversed by the antagonist prazosin. Isoproterenol administered intravenously at a dose of 0.01 to 10 mg./kg. and topically at 0.1 to 200 microg./ml. per minute decreased contraction frequency to 13% and 31% of controls, respectively. Contraction amplitude was not affected by intravenous administration but decreased to 59% of controls when applied topically. These effects were also observed with a slight delay in the saline perfused contralateral ureter. The heart rate also increased, suggesting absorption of the drug by the urothelium. The isoproterenol effects were blocked by the antagonist propranolol. Fenoterol administered intravenously at a dose of 0.1 to 30 microg./kg. and topically at 0.003 to 1 mg./ml. per minute decreased contraction frequency to 14% and 10% of controls, and contraction amplitude to 84% and 65%, respectively. These effects on the drug perfused ureter were also observed on the contralateral saline perfused ureter but to a lesser extent. The fenoterol effects were blocked by the antagonist propranolol. Papaverine administered intravenously at a dose of 0.001 to 3 mg./kg. decreased contraction frequency to 33% of controls. Topically administered papaverine as well as intravenous and topically administered rolipram had no relevant effect on ureteral motility.Intravenous phenylephrine increases, and isoproterenol and fenoterol decrease the frequency and amplitude of ureteral contractions in the pig. The same effects are observed with the topical administration of phenylephrine, which causes a significant local but not systemic side effect. Topical administration of isoproterenol and fenoterol produced local as well as systemic effects, suggesting absorption by the urothelium. However, to our knowledge a drug that relaxes ureteral peristalsis in pigs without causing systemic side effects has not yet been identified." @default.
• W2056500690 created "2016-06-24" @default.
• W2056500690 creator A5003374567 @default.
• W2056500690 creator A5028654330 @default.
• W2056500690 creator A5031852154 @default.
• W2056500690 creator A5048728644 @default.
• W2056500690 creator A5062089074 @default.
• W2056500690 creator A5075222976 @default.
• W2056500690 creator A5088959063 @default.
• W2056500690 date "2001-08-01" @default.
• W2056500690 modified "2023-10-11" @default.
• W2056500690 title "SYSTEMIC AND TOPICAL DRUG ADMINISTRATION IN THE PIG URETER: EFFECT OF PHOSPHODIESTERASE INHIBITORS α1, β AND β2-ADRENERGIC RECEPTOR AGONISTS AND ANTAGONISTS ON THE FREQUENCY AND AMPLITUDE OF URETERAL CONTRACTIONS" @default.
• W2056500690 cites W126100875 @default.
• W2056500690 cites W1892464155 @default.
• W2056500690 cites W1977659895 @default.
• W2056500690 cites W1984520738 @default.
• W2056500690 cites W1989489939 @default.
• W2056500690 cites W1991042915 @default.
• W2056500690 cites W1997946297 @default.
• W2056500690 cites W1998968159 @default.
• W2056500690 cites W2014666451 @default.
• W2056500690 cites W2019084343 @default.
• W2056500690 cites W2028711975 @default.
• W2056500690 cites W2034964546 @default.
• W2056500690 cites W2046733578 @default.
• W2056500690 cites W2054448396 @default.
• W2056500690 cites W2069526960 @default.
• W2056500690 cites W2069750023 @default.
• W2056500690 cites W2071232275 @default.
• W2056500690 cites W2072205750 @default.
• W2056500690 cites W2079669570 @default.
• W2056500690 cites W2080138576 @default.
• W2056500690 cites W2089671994 @default.
• W2056500690 cites W2104304359 @default.
• W2056500690 cites W2134368446 @default.
• W2056500690 cites W2164141509 @default.
• W2056500690 cites W2404160726 @default.
• W2056500690 cites W2411366435 @default.
• W2056500690 cites W2414752390 @default.
• W2056500690 cites W2418423491 @default.
• W2056500690 cites W2434179590 @default.
• W2056500690 cites W2474155339 @default.
• W2056500690 cites W4317564267 @default.
• W2056500690 doi "https://doi.org/10.1016/s0022-5347(05)66049-1" @default.
• W2056500690 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11458123" @default.
• W2056500690 hasPublicationYear "2001" @default.
• W2056500690 type Work @default.
• W2056500690 sameAs 2056500690 @default.
• W2056500690 citedByCount "52" @default.
• W2056500690 countsByYear W20565006902012 @default.
• W2056500690 countsByYear W20565006902013 @default.
• W2056500690 countsByYear W20565006902014 @default.
• W2056500690 countsByYear W20565006902016 @default.
• W2056500690 countsByYear W20565006902017 @default.
• W2056500690 countsByYear W20565006902020 @default.
• W2056500690 countsByYear W20565006902021 @default.
• W2056500690 countsByYear W20565006902022 @default.
• W2056500690 countsByYear W20565006902023 @default.
• W2056500690 crossrefType "journal-article" @default.
• W2056500690 hasAuthorship W2056500690A5003374567 @default.
• W2056500690 hasAuthorship W2056500690A5028654330 @default.
• W2056500690 hasAuthorship W2056500690A5031852154 @default.
• W2056500690 hasAuthorship W2056500690A5048728644 @default.
• W2056500690 hasAuthorship W2056500690A5062089074 @default.
• W2056500690 hasAuthorship W2056500690A5075222976 @default.
• W2056500690 hasAuthorship W2056500690A5088959063 @default.
• W2056500690 hasConcept C126322002 @default.
• W2056500690 hasConcept C126894567 @default.
• W2056500690 hasConcept C134018914 @default.
• W2056500690 hasConcept C163415756 @default.
• W2056500690 hasConcept C170493617 @default.
• W2056500690 hasConcept C2776664737 @default.
• W2056500690 hasConcept C2776885963 @default.
• W2056500690 hasConcept C2776952824 @default.
• W2056500690 hasConcept C2777952589 @default.
• W2056500690 hasConcept C2780253649 @default.
• W2056500690 hasConcept C2780648677 @default.
• W2056500690 hasConcept C42219234 @default.
• W2056500690 hasConcept C71924100 @default.
• W2056500690 hasConcept C84393581 @default.
• W2056500690 hasConcept C98274493 @default.
• W2056500690 hasConceptScore W2056500690C126322002 @default.
• W2056500690 hasConceptScore W2056500690C126894567 @default.
• W2056500690 hasConceptScore W2056500690C134018914 @default.
• W2056500690 hasConceptScore W2056500690C163415756 @default.
• W2056500690 hasConceptScore W2056500690C170493617 @default.
• W2056500690 hasConceptScore W2056500690C2776664737 @default.
• W2056500690 hasConceptScore W2056500690C2776885963 @default.
• W2056500690 hasConceptScore W2056500690C2776952824 @default.
• W2056500690 hasConceptScore W2056500690C2777952589 @default.
• W2056500690 hasConceptScore W2056500690C2780253649 @default.
• W2056500690 hasConceptScore W2056500690C2780648677 @default.
• W2056500690 hasConceptScore W2056500690C42219234 @default.
• W2056500690 hasConceptScore W2056500690C71924100 @default.
• W2056500690 hasConceptScore W2056500690C84393581 @default.
• W2056500690 hasConceptScore W2056500690C98274493 @default.
• W2056500690 hasIssue "2" @default.
• W2056500690 hasLocation W20565006901 @default.

• next